Skip to main content
Home
FULL MENU Close Menu
Home
Home

Ted Bosworth

News

More on GRADE: Cognitive deficits linked to CV risk factors in T2D

Author:
Ted Bosworth
Publish date: July 27, 2021

Hyperlipidemia and hypertension predict modest cognitive impairment even in diabetes of limited duration, but one expert urges caution: “The...

  • Read More

News

Medicare rules for CPAP penalize low-income patients for nonadherence

Author:
Ted Bosworth
Publish date: July 21, 2021

Adherence studies show a steady climb in adherence in all income groups initially, but “right at 90 days, there...

  • Read More

News

PCI after TAVR mostly succeeds, some risks identified

Author:
Ted Bosworth
Publish date: July 20, 2021

In a relatively large-scale registry analysis, angiography was performed successfully after TAVR in most cases.

  • Read More

News

DOACs linked to lower mortality than vitamin K antagonist: 3-year TAVR registry

Author:
Ted Bosworth
Publish date: July 16, 2021

Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.

  • Read More

News

Telemedicine is poised to drive new models of care

Author:
Ted Bosworth
Publish date: July 13, 2021

The effort to bring permanent coverage of telehealth services “the shared responsibility of every medical...

  • Read More

News

Patients’ sexual problems: Be proactive, make discussions routine

Author:
Ted Bosworth
Publish date: June 29, 2021

Elicit information about sexual health in the context of inquiring about other clinical issues, advised Dr. Anita H. Clayton.

  • Read More

News

Maintain OMT for 5 years after revascularization, boost survival at 10 years: SYNTAXES

Author:
Ted Bosworth
Publish date: June 29, 2021

Sustained optimal drug therapy after PCI or CABG is found to have major impact on mortality at 10 years, in an analysis of SYNTAX trial data.

  • Read More

News

Guidance provided for telepsychiatry in tardive dyskinesia

Author:
Ted Bosworth
Publish date: June 25, 2021

An in-person visit is preferred for initial evaluation and diagnosis of TD, Dr. Rif S. El-Mallakh reported.

  • Read More

News

AI-based software demonstrates accuracy in diagnosis of autism

Author:
Ted Bosworth
Publish date: June 25, 2021

“The lack of diagnostic tools for ASD in primary care settings contributes to an average delay of 3 years between first parental concern and...

  • Read More

News

Risk to infant may warrant drug treatment for postpartum depression

Author:
Ted Bosworth
Publish date: June 24, 2021

Persistent postpartum depression are associated with a more than fourfold risk of behavioral problems at the age of 3.5 years, Dr. Neha Hudepohl...

  • Read More

News

Long-acting injectable antipsychotics deserve first-line consideration

Author:
Ted Bosworth
Publish date: June 21, 2021

Circumventing large risks of nonadherence, long-acting injectables should be an option considered routinely, said Dr. Diana Perkins.

  • Read More

News

Telemedicine is poised to drive new models of care

Author:
Ted Bosworth
Publish date: June 19, 2021

A much larger role for telemedicine in clinical care appears inevitable after the COVID-19 pandemic experience.

  • Read More

News

Emerging drugs for schizophrenia targeting negative symptoms

Author:
Ted Bosworth
Publish date: June 17, 2021

Several antipsychotics that show efficacy against negative symptoms are in advanced stages of development, said Dr. Henry A. Nasrallah.

  • Read More

News

Western and proinflammatory diets are important drivers of gout risk

Author:
Ted Bosworth
Publish date: June 16, 2021

Western and proinflammatory diets are associated with increased risk of gout independent of other factors.

  • Read More

News

Secukinumab provides clinical benefit in phase 3 juvenile arthritis trial

Author:
Ted Bosworth
Publish date: June 15, 2021

Phase 3 trial shows secukinumab is effective for enthesitis-related arthritis and juvenile psoriatic arthritis in children.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close